3RKC
Hepatitis E Virus Capsid Protein E2s Domain (genotype IV)
3RKC の概要
| エントリーDOI | 10.2210/pdb3rkc/pdb |
| 関連するPDBエントリー | 3RKD |
| 分子名称 | Capsid protein (2 entities in total) |
| 機能のキーワード | viral capsid protein, viral protein |
| 由来する生物種 | Hepatitis E virus (HEV) |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 31977.62 |
| 構造登録者 | |
| 主引用文献 | Tang, X.H.,Yang, C.Y.,Gu, Y.,Song, C.L.,Zhang, X.,Wang, Y.B.,Zhang, J.,Hew, C.L.,Li, S.W.,Xia, N.S.,Sivaraman, J. Structural basis for the neutralization and genotype specificity of hepatitis E virus Proc.Natl.Acad.Sci.USA, 108:10266-10271, 2011 Cited by PubMed Abstract: Hepatitis E virus (HEV) causes acute hepatitis in humans, predominantly by contamination of food and water, and is characterized by jaundice and flu-like aches and pains. To date, no vaccines are commercially available to prevent the disease caused by HEV. Previously, we showed that a monoclonal antibody, 8C11, specifically recognizes a neutralizing conformational epitope on HEV genotype I. The antibody 8C11 blocks the virus-like particle from binding to and penetrating the host cell. Here, we report the complex crystal structure of 8C11 Fab with HEV E2s(I) domain at 1.9 Å resolution. The 8C11 epitopes on E2s(I) were identified at Asp(496)-Thr(499), Val(510)-Leu(514), and Asn(573)-Arg(578). Mutations and cell-model assays identified Arg(512) as the most crucial residue for 8C11 interaction with and neutralization of HEV. Interestingly, 8C11 specifically neutralizes HEV genotype I, but not the other genotypes. Because HEV type I and IV are the most abundant genotypes, to understand this specificity further we determined the structure of E2s(IV) at 1.79 Å resolution and an E2s(IV) complex with 8C11 model was generated. The comparison between the 8C11 complexes with type I and IV revealed the key residues that distinguish these two genotypes. Of particular interest, the residue at amino acid position 497 at the 8C11 epitope region of E2s is distinct among these two genotypes. Swapping this residue from one genotype to another inversed the 8C11 reactivity, demonstrating the essential role played by amino acid 497 in the genotype recognition. These studies may lead to the development of antibody-based drugs for the specific treatment against HEV. PubMed: 21642534DOI: 10.1073/pnas.1101309108 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.79 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






